FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Astellas Recalls Lots of Prograf and Astagraf

FDA says Astellas has recalled one lot each of its Prograf and Astagraf transplant medications that may contain empty capsules.

latest-news-card-1
Human Drugs

Bhargava Phytolab CGMP Violations

FDA warns Indias Bhargava Phytolab about CGMP issues in its manufacturing of finished drugs and active pharmaceutical ingredients.

latest-news-card-1
Human Drugs

FDA Wants Labeling Changes for Buprenorphine

FDA recommends that companies making transmucosal buprenorphine drugs indicated to treat opioid dependence revise the labeling to indicate there is no...

Human Drugs

FDA Approves Neurocrines Crenessity for CAH

FDA approves Neurocrine Biosciences Crenessity to be used with glucocorticoids to control androgen in adult and some pediatric patients with classic c...

Human Drugs

Endo Recalls Adrenalin Chloride Solution

FDA says Endo USA has recalled its Adrenalin Chloride Solution that predates the Federal Food, Drug, and Cosmetic Act and was never submitted for FDA ...

Human Drugs

FDA Warns 4 Online GLP-1 Sellers

FDA warns four companies it says are marketing unapproved copies of popular weight loss drugs.

Medical Devices

Global Unique Device ID Database Guidance

FDA publishes an updated Global Unique Device Identification Database guidance.

Human Drugs

Hikma Victoza Generic Approved by FDA

FDA approves Hikmas liraglutide injection, the first generic form of Novo Nordisks Victoza it has approved.

Human Drugs

Rhythm Gets Expanded Imcivree Indication

FDA approves an expanded indication for Rhythms Imcivree to include pediatric patients as young as age 2.

Human Drugs

Ionis Pharmaceuticals Tryngolza Approved for FCS

FDA approves Ionis Tryngolza as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome.